Home ›
Trademark Categories ›
Pharmaceuticals ›
2017 ›
IF ›
IFNARBYN
Trademark search for:
IFNARBYN
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2017-06-26 — Application filed
2017-06-29 — Application filed
2017-07-01 — Application filed
2017-09-22 — Assigned to examiner
2017-09-24 — Final disposition recorded
2017-09-24 — Final disposition recorded
2017-09-24 — Final disposition recorded
2018-02-20 — Teas change of correspondence received
2018-02-20 — Office action issued
2018-03-05 — Assigned to lie
2018-03-08 — Correspondence received in law office
2018-03-08 — Teas/email correspondence entered
2018-03-08 — Approved for pub - principal register
2018-03-09 — On hold - electronic record review required
2018-03-14 — Electronic record review complete
2018-03-28 — Notification of notice of publication e-mailed
2018-04-17 — Published for opposition
2018-04-17 — Official gazette publication confirmation e-mailed
2018-06-12 — Noa e-mailed - sou required from applicant
2018-11-27 — Sou teas extension received
2018-11-27 — Sou extension 1 filed
2018-11-27 — Sou extension 1 granted
2018-11-27 — Teas change of correspondence received
2018-11-29 — Notice of approval of extension request e-mailed
2019-02-08 — Teas change of correspondence received
2019-05-30 — Sou teas extension received
2019-05-30 — Sou extension 2 filed
2019-05-30 — Sou extension 2 granted
2019-06-01 — Notice of approval of extension request e-mailed
2019-08-08 — Teas revoke/app/change addr of atty/dom rep received
2019-08-08 — Attorney/dom.rep.revoked and/or appointed
2020-01-13 — Application abandoned
2020-01-13 — Application abandoned
2020-01-13 — Final status recorded
Owner Information
AstraZeneca AB
AstraZeneca AB
Correspondent
Wm. Charles Saunders ASTRAZENECA PHARMACEUTICALS LP
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
